SCHEMBL6401356

SCHEMBL6401356

COc1ccc(NS(=O)(=O)CN(CCCc2ccccc2)C(=O)CCC(C)CNC(=O)N2CCN(C)CC2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 2/20 0.41
NAMPT P43490 1/20 0.39
MMP1 P03956 1/20 0.39
MMP3 P08254 1/20 0.39
MMP7 P09237 1/20 0.39
MMP9 P14780 1/20 0.39
SIGMAR1 Q99720 1/20 0.38
CHRM5 P08912 2/20 0.38
CHRM1 P11229 2/20 0.38
CHRM3 P20309 2/20 0.38
GLA P06280 1/20 0.38
SLC1A2 P43004 1/20 0.38
ALDH1A1 P00352 3/20 0.38
GAA P10253 1/20 0.38
MAPK1 P28482 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
OPRM1 P35372 1/20 0.37
OPRD1 P41143 1/20 0.37
BMP1 P13497 1/20 0.37
MGAT2 Q10469 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6401369 0.87 ALOX5 (0.42) MMP1MMP3ALDH1A1SMN1; SMN2BMP1
SCHEMBL6408733 0.84 CA1 (0.42) MMP1MMP3ALDH1A1BMP1ALOX5
SCHEMBL6401353 0.80 MEN1 (0.40) PKMNAMPTMMP1MMP9SIGMAR1
SCHEMBL6403180 0.78 MMP3 (0.42) MMP1MMP3MMP9ALDH1A1GAA
SCHEMBL5443511 0.77 BLM (0.41) PKMNAMPTGLAALDH1A1
SCHEMBL6409464 0.75 ALOX5 (0.42) MMP1MMP3MMP9ALDH1A1BMP1
SCHEMBL6407167 0.74 CA1 (0.42) MMP1MMP3MMP7MMP9GLA
SCHEMBL6401317 0.74 NPC1 (0.47) NAMPTSIGMAR1ALDH1A1SMN1; SMN2OPRM1
SCHEMBL6401362 0.74 RAB9A (0.45) NAMPTMMP1MMP3SIGMAR1OPRM1
SCHEMBL6401375 0.74 NPC1 (0.39) MMP1MMP3MMP9SIGMAR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6900237-B2 Sulfonamide compounds as protease inhibitors AXYS PHARMACEUTICALS, INC. (US) 2005-05-31 US claimed
US-20030158231-A1 Sulfonamide compounds as protease inhibitors Celera Corporation 2003-08-21 US claimed
US-6900237-B2 Sulfonamide compounds as protease inhibitors AXYS PHARMACEUTICALS, INC. (US) 2005-05-31 US disclosed
US-20030158231-A1 Sulfonamide compounds as protease inhibitors Celera Corporation 2003-08-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030158231-A1 Sulfonamide compounds as protease inhibitors PRSS1, PRSS3, SPINT2 PKM 4037/4885NAMPT 375/4885MMP1 288/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.